Advertisement

Topics

Ellipsis Biotherapeutics Corporation Company Profile

10:34 EDT 26th September 2018 | BioPortfolio

Ellipsis Biotherapeutics Corporation provides commercial genotyping services, including research capabilities for development of novel genetic tests and gene discovery. It was incorporated in Ontario, Canada, in 1997.As part of its founding mission to investigate genetic susceptibility to inflammatory disease, Ellipsis established fully automated high throughput SNP analysis capabilities. Ellipsis has leveraged this core expertise in human disease research and genetic analysis to provide superior quality genotyping services to government, academic and industrial clients.

Location

700 Bay Street Suite 2101, Box 195
Toronto
Ontario
M5G 1Z6
Canada

Contact

Phone: 416.586.0281
Fax: 416.586.0638
Email: mailto:genotyping@ellipsisbio.com


News Articles [316 Associated News Articles listed on BioPortfolio]

Pre-Market Technical Scan on Biotech Equities -- Eleven Biotherapeutics, Endocyte, Esperion ...

www.wallstequities.com/registration Eleven Biotherapeutics On Wednesday, shares in Cambridge, Massachusetts-based Eleven Biotherapeutics Inc. recorded a trading volume of 1.09 million shares, whic...

Codexis Appoints Biotherapeutics R&D VP

Dr. Alaoui will be responsible for the biotherapeutics discovery pipeline and acceleration of drug candidates to the clinic

Cancer Research UK launches new research hub for biotherapeutics

Cancer Research UK has launched a global centre of excellence in London to facilitate research on biotherapeutics as a treatment...Read More... The post Cancer Research UK launches new research hub fo...

Pall and Celltheon form strategic biotherapeutics partnership

This partnership will deliver integrated manufacturing solutions for customers developing biotherapeutics

BRIEF—Eleven Biotherapeutics changes name to Sesen Bio

USA-based oncology specialist Eleven Biotherapeutics has announced that the company is changing its name…

Improving understanding of biotherapeutics and biosimilars

Additional information on biosimilars and biotherapeutics have been published in Europe.

Gene Biotherapeutics sells Excellagen technology platform to Olaregen

Olaregen is a special purpose entity which was formed by an unaffiliated investment group to acquire and commercialize advanced wound healing therapeutics for multiple vertical markets. Gene Biotherap...

Deals this week: Aeglea BioTherapeutics, BerGenBio, Evelo Biosciences

Aeglea BioTherapeutics intends to raise funds for its ongoing research and development (R&D), production and regulatory activities and other purposes....Read More... The post Deals this week: Aegl...

PubMed Articles [28 Associated PubMed Articles listed on BioPortfolio]

Processing of ellipsis with garden-path antecedents in French and German: Evidence from eye tracking.

In a self-paced reading study on German sluicing, Paape (Paape, 2016) found that reading times were shorter at the ellipsis site when the antecedent was a temporarily ambiguous garden-path structure. ...

Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity.

Recent advances in synthetic biology and biological system engineering have allowed the design and construction of engineered live biotherapeutics targeting a range of human clinical applications. In ...

Cell Penetration Profiling Using the Chloroalkane Penetration Assay.

Biotherapeutics are a promising class of molecules in drug discovery, but they are often limited to extracellular targets due to their poor cell penetration. High-throughput cell penetration assays ar...

Integrated BioTherapeutics.

Live bacterial biotherapeutics in the clinic.

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)

The purpose of this study is to: - evaluate the safety profile of a single intravenous administration of AIGIV (containing either 3.5 mg/kg, 7.0 mg/kg or 14.0 mg/kg anti-PA IgG) a...

A Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Mitochondrial Disease Previously Treated in the Stealth BioTherapeutics SPIMM-201 Study

This is a Phase 2, randomized, double-blind, placebo-controlled crossover study which will enroll up to 36 subjects (anticipated) with genetically confirmed mitochondrial disease who have ...

The Effect of OASIS Ultra on Critical Sized Wound Healing

The aim of this study is to evaluate the speed and quality with which OASIS® Ultra (Healthpoint Biotherapeutics; Fort Worth, Texas) increases wound healing in the critical sized defect. ...

Personalized Immunotherapeutics for Antibiotic-resistant Infection

M. A. suffers from hypogammaglobulinemia that has been complicated by refractory Mycoplasma hominis septic arthritis. He has been receiving the antibiotic valnemulin under Emergency Invest...

Companies [276 Associated Companies listed on BioPortfolio]

Ellipsis Biotherapeutics Corporation

Ellipsis Biotherapeutics Corporation provides commercial genotyping services, including research capabilities for development of novel genetic tests and gene discovery. It was incorporated in Ontario,...

Axial Biotherapeutics

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and the central nervous system to develop a new class of biotherapeutics ...

Napro Biotherapeutics Incorporated

NaPro BioTherapeutics, Inc. is a natural product pharmaceutical company focused primarily on the development, manufacture and commercializa tion of paclitaxel, a naturally-occurring anti-cancer agent ...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Sephos Biotherapeutics

Sephos Biotherapeutics is a privately owned company focused on designing drugs for the treatment of cancer stem cells where the structure and biological activity of the drugs have...

More Information about "Ellipsis Biotherapeutics Corporation" on BioPortfolio

We have published hundreds of Ellipsis Biotherapeutics Corporation news stories on BioPortfolio along with dozens of Ellipsis Biotherapeutics Corporation Clinical Trials and PubMed Articles about Ellipsis Biotherapeutics Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ellipsis Biotherapeutics Corporation Companies in our database. You can also find out about relevant Ellipsis Biotherapeutics Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record